Overcoming Stereotypes Of “Emerging Markets” In Business Decisions
Below, I explain in greater detail the disconnect between common perceptions and realities of emerging markets using examples ...
The number of people considered a 'healthy weight' is dropping. Here’s why.
While it seems like we’re getting slimmer as a population, a new report suggests that’s not necessarily the case: It found ...
Can smallcap stocks crash trigger a capitulation phase? What analysts say
Nearly 60% of the SmallCap stocks registered a sharper loss compared to the Nifty SmallCap 100 and SmallCap 250 indices, ...
Weekly Indicators: Confirming The 'Steady As She Goes' Economy
Long leading indicators remain neutral, with improved corporate profits but flat yield curves. Read why economic outlook is ...
Is China’s military really built for war? New report questions Beijing’s arms buildup
China is not ready for war, according to a contentious report from a US think tank, which claims the main motivation for the ...
Private companies in Heineken N.V. (AMS:HEIA) are its biggest bettors, and their bets paid off as stock gained 16% last week
Key Insights Significant control over Heineken by private companies implies that the general public has more power ...
journalgazette1d
Reliable access to food among challenges Hoosier children face, report says
The number of Hoosier children experiencing food insecurity has increased 40% following three years of steady decline – a ...
Monitordaily6d
Customer Satisfaction Drives Financial Strength, Even as CX Struggles
Despite mounting doubts about the effectiveness of customer experience management, customer satisfaction remains a key driver ...
Dollarama Inc. (TSE:DOL) most popular amongst retail investors who own 55% of the shares, institutions hold 44%
Key Insights Significant control over Dollarama by retail investors implies that the general public has more power ...
Should you use weight loss drugs? First, measure obesity right.
There's a boom in the use of weight loss medications with more new ones on their way, but they are recommended only for the clinically obese A slew of new weight loss drugs are being tested in 2025.
Davis New York Venture Fund 2025 Annual Review
Davis New York Venture Fund returned +17.51% in 2024. The fund has consistently grown wealth for shareholders since its ...